TRIA
UTHR icon

Trail Ridge Investment Advisors’s United Therapeutics UTHR Stock Holding History

Trail Ridge Investment Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54M Buy
2,600
+118
+5% +$58.8K 0.67% 40
2025
Q4 		$1.21M Buy
2,482
+226
+10% +$105K 0.52% 46
2025
Q3 		$946K Buy
2,256
+44
+2% +$14.8K 0.42% 52
2025
Q2 		$608K Hold
2,212
– – 0.29% 63
2025
Q1 		$682K Buy
2,212
+85
+4% +$29.1K 0.35% 56
2024
Q4 		$750K Sell
2,127
-3
-0.1% -$1.1K 0.36% 58
2024
Q3 		$751K Sell
2,130
-49
-2% -$16.6K 0.36% 58
2024
Q2 		$694K Buy
2,179
+234
+12% +$61.9K 0.36% 61
2024
Q1 		$447K Buy
1,945
+310
+19% +$70K 0.25% 71
2023
Q4 		$360K Buy
1,635
+110
+7% +$25.4K 0.22% 81
2023
Q3 		$344K Buy
1,525
+43
+3% +$9.9K 0.23% 80
2023
Q2 		$327K Buy
1,482
+362
+32% +$80.2K 0.2% 92
2023
Q1 		$251K Buy
+1,120
New +$276K 0.16% 104

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Trail Ridge Investment Advisors's UTHR Position: Q1 2026 in Review

Trail Ridge Investment Advisors increased its United Therapeutics (UTHR) stake by 4.8% in Q1 2026, buying an estimated $58.8K and bringing the position to 2,600 shares worth $1.54M. The position accounts for 0.67% of the portfolio, ranked #40.

Trail Ridge Investment Advisors first reported a position in UTHR in Q1 2023 and has held it in 13 quarters since. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Trail Ridge Investment Advisors held 2,600 shares of United Therapeutics worth $1.54M as of Q1 2026.
  • Trail Ridge Investment Advisors bought 118 United Therapeutics shares in Q1 2026, an estimated $58.8K.
  • United Therapeutics made up 0.67% of Trail Ridge Investment Advisors's portfolio in Q1 2026, its #40 holding.
  • Trail Ridge Investment Advisors first reported a position in United Therapeutics in Q1 2023 and has held it in 13 quarters since.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Trail Ridge Investment Advisors's 13F filing for Q1 2026, filed 5 May 2026.